Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: Advances and open questions

被引:24
作者
Bock, Karl Walter [1 ]
Koehle, Christoph [1 ]
机构
[1] Univ Tubingen, Inst Pharmacol & Toxicol, Dept Toxicol, D-72074 Tubingen, Germany
关键词
UDP-glucuronosyltransferases; UGT topology in endoplasmic; reticulum membranes; UGT oligomers; Diglucuronide formation; beta-Glucuronidase; RADIATION-INACTIVATION ANALYSIS; HUMAN DRUG GLUCURONIDATION; HUMAN LIVER-MICROSOMES; IN-VITRO; DIGLUCURONIDE FORMATION; BETA-GLUCURONIDASE; RAT-LIVER; CONJUGATED METABOLITES; NOMENCLATURE UPDATE; IRINOTECAN TOXICITY;
D O I
10.1016/j.bcp.2008.12.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-glucuronosyltransferases (UGTs) represent major Phase H enzymes involved in detoxification of endo- and xenobiotics, including many drugs. The intraluminal orientation of the active site of UGTs in endoplasmic reticulum membranes necessitates a number of transporters in these membranes, for example, for UDP-glucuronic acid and glucuronides, the latter being insufficiently characterized. in addition, accumulating evidence suggests that UGTs are functional as homo- and heterodimers in monoglucuronide formation. They may form tetramers in diglucuronide formation. UGT oligomers probably serve to stabilize UGT monomers and fine-tune UGT activity. Glucuronide disposition may also be influenced by endoplasmic reticulum-localized beta-glucuronidase, possibly involved in hydrolysis of hormone and drug glucuronides in target cells. The present commentary reviews recent advances and addresses open questions. Resolution of these questions may help to understand many problems of glucuronide synthesis and disposition in vivo, for example, under-prediction of the in vivo clearance of drugs mostly eliminated by glucuronidation by in vitro enzyme kinetic parameters of UGTs. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1458 / 1465
页数:8
相关论文
共 68 条